The information below serves as a guide in defining and determining what health programs and services are provided by the pharmacy. Explanatory text may be used to support the definition. In the event of conflict between these, the definition is authoritive over the explanatory text.

Opioid Substitution Program

Related Checklist T3A
A harm minimisation treatment program for opioid dependence offered by the pharmacy, usually in conjunction with a state/territory health program.

Service explanation
Opioid substitution programs aim to reduce the health, social and economic harms to individuals and the community arising from illicit opioid use. Pharmacies offering this service provide an accessible treatment program; assisting clients effectively manage their opioid dependence. The program aims to reduce the risks and harms associated with drug use, and to improve the quality of life of patients. Methadone, buprenorphine or buprenorphine/naloxone combination products are used as an opioid substitute.

Dose Administration Aid

Related Checklist T3B
As defined by Standard 7 of the PSA Professional Practice Standards.
Service explanation
DAAs are compliance devices designed to assist medication management for a patient by having their medicines divided into individual doses and arranged into a dose schedule through the day. DAAs may include unit dose packing (where the dose [one or more tablets] of a single type of medication is packed in each compartment, blister or sachet), or multi-dose packing (where doses of more than one medicine can be packed in a compartment, blister or sachet).

Needle and Syringe Program

Related Checklist T3D
A service where the pharmacy supplies equipment used to prepare and administer illicit drugs as a public health harm minimisation measure. The service may also include safe disposal of used equipment returned to the pharmacy.

Service explanation
Needle and syringe programs are often delivered in conjunction with state/territory health departments. As such, the nature of the service varies between jurisdictions. Community pharmacies provide clean injecting equipment and safe disposal of used equipment. The service aims to reduce the spread of blood diseases such as hepatitis and HIV. Pharmacies providing this service supply needles and sharps containers. Returned containers must be kept out of reach of children.

Smoking Cessation Service

Related Checklist T3E
A structured management program to assist consumers to quit smoking.

Service explanation
A smoking cessation program may include, quit management plans, ongoing counselling, monitoring, support and referral services. Some pharmacies may also use retail navigation boards on smoking cessation products. A pharmacy selling only nicotine replacement products (NRT) and other stop smoking aids is not providing a smoking cessation service.

Medications Management Review (MMR)

Related Checklist T3F
As defined by Standard 4 under ‘medication review’ in the PSA Professional Practice Standards.

Service explanation
An MMR is a comprehensive medication review service conducted by accredited pharmacists.  It includes funded Home Medicine Review (HMR) and Residential Medication Management Review (RMMR) services.

Services to Residential Care Facilities

Related Checklist T3G
As defined by Standard 8 of the PSA Professional Practice Standards.

Service explanation
The quality use of medicines services will usually be provided by the pharmacy under a contract with a Residential Care Facility. Services provided may include timely access to medicines, medicines advice and provision of medicines.  The scope of this service is further described in Standard 8 of the PSA’s Professional Practice Standard.

Health Promotion

Related Checklist T3H
A process/activity where the pharmacy actively engages consumers and the community to promote health and wellbeing at a group or population level.

Service explanation
Health promotion is a planned activity with the intent of increasing health in a number of people. This could include community development, health education, health information and social marketing. The service may be provided in various settings, such as the pharmacy, schools, workplaces or public spaces.  For the purposes of QCPP, health promotion must be directed at a group or a population (not opportunistic one-on-one counselling).

Disease State Management

Related Checklist T3I
As defined by Standard 4 of the PSA Professional Practice Standards.

Service explanation
Disease state management services support consumers to manage chronic health conditions. They are delivered to consumers who have been diagnosed with a disease that entails monitoring and ongoing management. Disease state management services may focus on improving medication adherence; improving a consumer’s understanding and use of their medicines; assisting with lifestyle support; supporting self-management of co-morbidities and increasing health literacy.  The service must be offered as part of an ongoing cycle of care. Areas of service may include, but are not limited to, diabetes, asthma, Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular disease.

Medicine Adherence Program

Related Checklist T3J
A program that encourages consumers to take prescribed medicines consistently and according to the regimen intended.

Staged Supply

Related Checklist T2F
As described by the PSA’s ‘Standard and guidelines for pharmacist providing a staged supply service for prescribed medicines’.

Service explanation
For the purpose of clarity, staged supply within opioid substitution programs is specifically excluded from this definition.

Interprofessional Collaboration

Related Checklist T2E
A two-way interaction between a pharmacist and other health professional in the interest of a patient or group of patients.

Service explanation
Only collaboration with specified health practitioners is a two way communication to promote the health and wellbeing of a consumer or consume group. In isolation, “one-way” communication, such sending as a referral letter does not constitute inter-professional collaboration.

In-Pharmacy Medicine Review

Related Checklist T3K
A face-to-face medicine review conducted in a community pharmacy.

Service explanation
An in-pharmacy review of a consumer’s medicines focuses on education and self-management and aims to:

  • Identify problems that the consumer may be experiencing with their medicines
  • Help the consumer learn more about their medicines including how medicines affect medical conditions
  • Improve the effective use of medicines by consumers
  • Educate consumers about how to best use and store their medicines
Medscheck and Diabetes Medscheck are considered in-pharmacy medication review services. In addition to the above, Diabetes Medschecks:
  • Optimise a consumer’s effective use of medicine through improving understanding of, and compliance with, their diabetes medication therapy
  • Improve a consumer’s effective use of blood glucose monitoring devices through training and education
  • Improve blood glucose control
  • Reduce the risk of the consumer developing complications associated with type 2 diabetes


Related Checklist T3C
As defined the PSA Professional Practice Standards.

Service explanation:
Screening involves a process of undergoing tests or questions to identify individuals who may have a disease and require more specific investigation. Such individuals would normally be referred to other health care professionals for a diagnosis. Examples of screening tests could include a PiKO-6 test for COPD. Screening services may sometimes be combined with, and offered in response to risk identified in a risk assessment service.

Risk Assessment

As defined by the PSA Professional Practice Standards.

Service explanation:
Risk assessment involved identifying consumers who are at a high relative or absolute risk of developing a health condition, or people who are currently undiagnosed. It generally identifies presence of factors which place an individual at an increased risk of a health condition. A risk assessment activity may result in recommendations to reduce risk, such as lifestyle adjustment or referral to another health professional. Examples of risk assessment tools include the AUSDRISK (type 2 diabetes risk assessment), lung health checklist (COPD and other lung conditions) and the Australian Absolute cardiovascular disease risk calculator.

Clinical Interventions

As defined by the PSA Professional Practice Standard for Clinical Interventions.


Any representation intended to promote the use of a good or service.


In relation to training, guidelines or similar, ‘approved’ refers to an activity or reference which is recognised by QCPP.


A person endorsed by QCPP to carry out QCPP Assessments

Asthma Devices

Medical devices used to assist the management of asthma. Common devices include spacers, face masks and aids to use Metered Dose Inhalers (MDI)

Blood Glucose Monitor

Point-of-care medical device used to measure the concentration of glucose in blood.

Blood Pressure Monitor

Point-of-care medical device used to measure blood pressure.

Business Continuity Plan

A plan designed to help your pharmacy respond to a crisis event, minimise interruptions, recover and resume normal operations as quickly as possible. A crisis event may be a fire, flood, loss of key staff, pandemic etc.


A process of ensuring a device reads or takes measurements accurately, in accordance with its manufacturer’s instructions.

Clinical Day Book
For the purpose of Opioid Substitution Programs, a clinical day book is a record of provision of methadone and buprenorphine. The aim of the Clinical Day Book is to prevent complications such as duplicate dispensing, and may be a legal requirement in some states/territories.


Approved Consumer Medicines Information.

Complex Compounding

Is the preparation and supply of a single unit of a sterile product (by aseptic technique or end sterilisation) that is intended for immediate use by a specific consumer.


Is the preparation and supply of a single unit of a non-sterile product intended for immediate use by a specific consumer.

Consultation Area

An identifiable area or separate room within the Professional Services Area that allows for:

  • Confidential interactions
  • Conversations at normal speaking volume without being overheard by others.


A person, who is not an employee of the pharmacy, contracted to move goods to or from the pharmacy.

Cytotoxic Medicines

Medicines which have a deleterious effect upon cells and may be mutagenic, teratogenic or carcinogenic. These medicines are predominantly used to treat cancer or autoimmune disorders and require special handling.


A formal statement by a person specifying facts and circumstance.


The transport of goods from the pharmacy to another location, usually by pharmacy staff. It does not include transport of goods defined to be distance supply.


Provision of medicines as set on a lawful prescription.

Dispensing Assistant

As defined in section 3.2 of AS 85000 Quality Care Pharmacy Standard
Explanatory text
The Standard defines dispensary assistant as:
A suitably trained person who assists a pharmacist in the dispensing of medicines, in the dispensing area of a pharmacy business or pharmacy department, in accordance with procedures and guidelines.

Distance supply

As described by ‘indirect supply’ in Standard 6 of the PSA Professional Practice Standard.
Service explanation
Distance supply is considered to be when a pharmacy supplies a dispensed medicine, Pharmacist Only Medicine or Pharmacy Medicine direct to a consumer via a delivery service that is run by a contractor. That is, if an item is delivered by a member of the pharmacy’s staff it is considered to be a delivery (covered under Element 11 Action 5).
Delivery of medicines between the pharmacy and an aged cared residential facility is not considered direct to a consumer (rather, delivery between two health facilities) and therefore delivery by a contractor maybe covered by a third party agreement.


Home Medicines Review

Lapsed Pharmacy

A pharmacy whose accreditation has expired or has been revoked. This occurs when:

  • the period of accreditation has expired and the pharmacy has not successfully undergone reaccreditation; or
  • when a pharmacy's accreditation has been revoked as a sanction due to non-conformance with either the QCPP Program Rules and/or QCPP Requirements; or
  • failure of a pharmacy to pay fees or charges associated with QCPP Accreditation


The SI unit of illuminance (i.e. brightness of light)


The process of preserving a condition or situation or the state of being preserved


As defined in the Therapeutic Goods Act.
Medicines are goods represented to achieve an intended health benefit by pharmacological, chemical, immunological or metabolic means in or on the body. This can include, but is not limit to; tablets, capsules, suspensions, creams, ointments, inhalations, injections and patches used to treat, manage or prevent diseases or ailments.  For clarity, this definition includes all prescription medicines, non-prescription medicines and complementary medicines – including vitamin, mineral, herbal and homeopathic medicines.

Medical Device

As defined in section 3.3 of AS 85000 Quality Care Pharmacy Standard
Explanatory text
The Standard defines medical devices as:
A medical device is any instrument, apparatus, appliance, material or other article (whether used alone or in combination, and including the software necessary for its proper application) intended to be used for human beings for the purpose of one or more of the following:

a) Diagnosis, prevention monitoring, treatment or alleviation of a disease;
b) Diagnosis monitoring, treatment, alleviation of or compensation for an injury of handicap;
c) Investigation, replacement or modification of the anatomy or of a physiological process;
d) Control of conception; and
e) That does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means; or
f) An accessory to such an instrument, apparatus, appliance, material or other article.


Place of Business operated by a pharmacy operator as a retail pharmacy outlet

Pharmacy Medicine

A substance in Schedule 2 of the SUSMP or equivalent document.

Pharmacy Operator

A person, partnership of persons, associations of persons, company of a deceased person, being an employer and as such carrying on the business and profession of a pharmacist, individually or in a partnership in private practice within the Commonwealth of Australia or its territories

Pharmacist Only Medicine

A substance in Schedule 3 SUSMP or equivalent document.


Patient Record Form

Price List

A list of prices for products sold by the pharmacy, usually predominately in the context of Prescription Medicines.


A sequential set of steps which describes a process for doing something.

Professional Services Area

As defined in section 3.5 of AS 85000 Quality Care Pharmacy Standard
Explanatory text
The Standard defined the Professional Services Area as:
An area established within a pharmacy where only health related products and services are provided. The Professional Services Area is a continuous section within the pharmacy and includes the dispensary, a counseling area, and a place for the receipt of prescriptions and supply of prescription medicines as well as the storage of non-prescription therapeutic goods. The Professional Services Area should enable general supervision by the duty pharmacist and the opportunity for pharmacy assistants to efficiently interact with customers. The Professional services Area should not contain any non-health related products or services.

Project Stop

An online decision support tool for the supply and recording of pseudoephedrine sales administered by The Pharmacy Guild of Australia aimed at prevention the diversion of pseudoephedrine to the manufacture of illicit drugs.


Activities intended to encourage the purchase or use of goods or services.

Recognised Course

A course recognised by QCPP.


Abbreviation for Return of Unwanted Medicines Program.

RUM approved container

A container for the disposal of medicines approved by the RUM program.


As defined in section 3.7 of AS 85000 Quality Care Pharmacy Standard
Explanatory notes
The Standard describes system as:
When “system” is used in the context of a requirement in this standard, a documented procedure and process for recording, training and reviewing the procedure is required.

Schedule 7

Substances in Schedule 7 of the Standard for the Uniform Scheduling of Medicines and Poisons. These substances are known as Dangerous Poisons

Scheduled medicines

Medicines contained in the Standard for the Uniform Scheduling of Medicines and Poisons, often used only in the context of Pharmacy Medicines and/or Pharmacist Only Medicines

Self Assessment

The evaluation of performance without external input.


Selection of products from a shelf or similar without assistance from pharmacy staff.

Simple compounding

As defined by ‘extemporaneous dispensing’ in the Australian Pharmaceutical Formulary and Handbook (APF).

The APF23 defines extemporaneous dispensing as: The preparation and supply of a single 'unit of issue' of a therapeutic product intended for a specific person in response to an identified need.
Explanatory text
The APF22 defines extemporaneous dispensing as:
The preparation and supply of a single ‘unit of issue’ of a therapeutic product intended for immediate use by a specific person in response to an identified need.


Standard for the Uniform Scheduling of Medicines and Poisons.

Therapeutic Good

A medicine or medical device listed on the ARTG, or otherwise recognized by the TGA as a therapeutic good. 

Therapeutic Goods are products which are for therapeutic use, such as preventing, diagnosing, curing, alleviating a human disease, ailment, defect or injury. Products traditionally used as foods and cosmetic claims are generally not considered therapeutic goods. More information about what constitutes a therapeutic good can be found on the TGA website at

Explanatory text
Therapeutic Goods are products which are for therapeutic use, such as preventing, diagnosing, curing, alleviating a human disease, ailment, defect or injury. Products traditionally used as foods and cosmetic claims are generally not considered therapeutic goods. More information about what constitutes a therapeutic good can be found on the TGA website at

Back To Top↑

© The Pharmacy Guild of Australia | Disclaimer | Privacy Policy | Contact Us